- Synonyms2-(2-amino-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-4-chlorophenyl)acetic acid;Benzeneacetic acid, 2-amino-5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-;2-(2-Amino-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-4-chlorophenyl)acetic acid;ZIPRASIDONE AMINO...
- Description
2-(2-amino-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-4-chlorophenyl)acetic acid;Benzeneacetic acid, 2-amino-5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-;2-(2-Amino-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-4-chlorophenyl)acetic acid;ZIPRASIDONE AMINO ACID SODIUM SALT(ZIPRASIDONE IMPURITY C);1,2-Seco-ziprasidone;Ziprasidone hydrochloride impurity, ziprasidone open ring- [USP];Ziprasidone Amino Acid
Ziprasidone EP Impurity C is a fully characterized chemical compound used as a reference standard of API Ziprasidone. The standard offered is compliant with regulatory guidelines. Ziprasidone EP Impurity C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1159977-64-6